These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 17354472)
21. Contribution of polyunsaturated fatty acids to Shiga toxin cytotoxicity in human renal tubular epithelium-derived cells. Sasaki TK; Takita T Biochem Cell Biol; 2006 Apr; 84(2):157-66. PubMed ID: 16609696 [TBL] [Abstract][Full Text] [Related]
22. Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome. Fernández GC; Ramos MV; Gómez SA; Dran GI; Exeni R; Alduncín M; Grimoldi I; Vallejo G; Elías-Costa C; Isturiz MA; Palermo MS J Leukoc Biol; 2005 Oct; 78(4):853-61. PubMed ID: 16046554 [TBL] [Abstract][Full Text] [Related]
23. Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome. Fernández GC; Rubel C; Barrionuevo P; López L; Ramirez F; Díaz M; Isturiz MA; Palermo MS Pediatr Nephrol; 2002 May; 17(5):337-44. PubMed ID: 12042890 [TBL] [Abstract][Full Text] [Related]
24. The role of the endothelium in hemolytic uremic syndrome. Zoja C; Morigi M; Remuzzi G J Nephrol; 2001; 14 Suppl 4():S58-62. PubMed ID: 11798147 [TBL] [Abstract][Full Text] [Related]
25. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818 [TBL] [Abstract][Full Text] [Related]
27. Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome. Gómez SA; Fernández GC; Camerano G; Dran G; Rosa FA; Barrionuevo P; Isturiz MA; Palermo MS Clin Exp Immunol; 2005 Jan; 139(1):65-73. PubMed ID: 15606615 [TBL] [Abstract][Full Text] [Related]
28. Impaired neutrophils in children with the typical form of hemolytic uremic syndrome. Fernández GC; Gómez SA; Rubel CJ; Bentancor LV; Barrionuevo P; Alduncín M; Grimoldi I; Exeni R; Isturiz MA; Palermo MS Pediatr Nephrol; 2005 Sep; 20(9):1306-14. PubMed ID: 15940545 [TBL] [Abstract][Full Text] [Related]
29. Shiga toxin-producing Escherichia coli and their bacteriophages as a model for the analysis of virulence and stress response of a food-borne pathogen. Creuzburg K; Schmidt H Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):288-95. PubMed ID: 17715821 [TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Ray PE; Liu XH Pediatr Nephrol; 2001 Oct; 16(10):823-39. PubMed ID: 11605791 [TBL] [Abstract][Full Text] [Related]
31. Interactions of Shiga-like toxin with human peripheral blood monocytes. Geelen JM; van der Velden TJ; van den Heuvel LP; Monnens LA Pediatr Nephrol; 2007 Aug; 22(8):1181-7. PubMed ID: 17574480 [TBL] [Abstract][Full Text] [Related]
32. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Fernandez GC; Lopez MF; Gomez SA; Ramos MV; Bentancor LV; Fernandez-Brando RJ; Landoni VI; Dran GI; Meiss R; Isturiz MA; Palermo MS Clin Exp Immunol; 2006 Oct; 146(1):76-84. PubMed ID: 16968401 [TBL] [Abstract][Full Text] [Related]
33. Association of haemolytic uraemic syndrome with dysregulation of chemokine receptor expression in circulating monocytes. Ramos MV; Ruggieri M; Panek AC; Mejias MP; Fernandez-Brando RJ; Abrey-Recalde MJ; Exeni A; Barilari C; Exeni R; Palermo MS Clin Sci (Lond); 2015 Aug; 129(3):235-44. PubMed ID: 25748554 [TBL] [Abstract][Full Text] [Related]
34. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972 [TBL] [Abstract][Full Text] [Related]
35. Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome. Fernández GC; Rubel C; Dran G; Gómez S; Isturiz MA; Palermo MS Clin Immunol; 2000 Jun; 95(3):227-34. PubMed ID: 10866130 [TBL] [Abstract][Full Text] [Related]
36. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698 [TBL] [Abstract][Full Text] [Related]
38. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission]. Rivas M; Miliwebsky E; Chinen I; Deza N; Leotta GA Medicina (B Aires); 2006; 66 Suppl 3():27-32. PubMed ID: 17354474 [TBL] [Abstract][Full Text] [Related]
39. Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome. Exeni RA; Fernández GC; Palermo MS ScientificWorldJournal; 2007 Aug; 7():1155-64. PubMed ID: 17694250 [TBL] [Abstract][Full Text] [Related]
40. Is immune cell activation the missing link in the pathogenesis of post-diarrhoeal HUS? Heyderman RS; Soriani M; Hirst TR Trends Microbiol; 2001 Jun; 9(6):262-6. PubMed ID: 11390240 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]